Tacrolimus to cyclosporine microemulsion formulation conversion in the pediatric liver transplant patient.
Falkenstein
K
K
St Christopher's Hospital for Children, Philadelphia, Pennsylvania 19134, USA.
Dunn
S
S
D000284:Administration, Oral; D000293:Adolescent; D001786:Blood Glucose / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000139:chemically induced; D004655:Emulsions; D005500:Follow-Up Studies; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007223:Infant; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D016559:Tacrolimus / Q000009:adverse effects*; D013997:Time Factors
D001786:Blood Glucose; D004655:Emulsions; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus